First Ascent Biomedical
PrivateLast Round
Grant
Mar 3, 2025
Total Funding Raised
$4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
First Ascent Biomedical is a biotechnology company that provides a drug prediction platform designed to deliver personalized cancer treatment planning for patients.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical AI, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
First Ascent Biomedical Comparables
Compare First Ascent Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Travera | 87% | |
| SageMedic Corp. | 84% | |
| Xilis | 80% |
First Ascent Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 3, 2025 | ||||
| Grant | Feb 28, 2025 | ||||
| VC Round | Jan 13, 2025 |
Key People
Founding team and executive leadership
First Ascent Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pennsylvania Department of Community and Economic Development | Grant |
| Ben Franklin Technology Partners of Central & Northern PA | Grant |
| Techstars | VC Round |
| Florida Department of Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 111% MoM, reaching 3.6K.
- Jul 20, 2026
Grew 18% QoQ, from 17 to 20 employees.
First Ascent Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about First Ascent Biomedical's valuation, stock price, and market status.
Is First Ascent Biomedical a public or private company?
First Ascent Biomedical is a private company.
What is the current stock price of First Ascent Biomedical?
First Ascent Biomedical is a private company, so its shares have no public market price. Caplight tracks First Ascent Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is First Ascent Biomedical worth (valuation)?
Valuation information for First Ascent Biomedical is not publicly available.
Can I buy First Ascent Biomedical stock?
First Ascent Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was First Ascent Biomedical's last funding round?
First Ascent Biomedical's most recent funding round was Grant on March 3, 2025.
Who are the main investors in First Ascent Biomedical?
Key investors in First Ascent Biomedical include Pennsylvania Department of Community and Economic Development, Ben Franklin Technology Partners of Central & Northern PA, Techstars, Florida Department of Health.
Will First Ascent Biomedical IPO soon?
No public IPO plans have been announced for First Ascent Biomedical.
How can I track First Ascent Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in First Ascent Biomedical's shares on secondary markets.